CN110302282A - Herba Patriniae extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug - Google Patents
Herba Patriniae extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug Download PDFInfo
- Publication number
- CN110302282A CN110302282A CN201910493121.7A CN201910493121A CN110302282A CN 110302282 A CN110302282 A CN 110302282A CN 201910493121 A CN201910493121 A CN 201910493121A CN 110302282 A CN110302282 A CN 110302282A
- Authority
- CN
- China
- Prior art keywords
- acinetobacter bauamnnii
- drug
- extract
- field pennycress
- herba patriniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses Herba Patriniae extracts to prepare the application in overriding resistance Acinetobacter bauamnnii drug.The present invention treats the nematode for having infected drug resistance Acinetobacter bauamnnii using the extract of field pennycress, show that the extract of field pennycress has good bactericidal effect to drug resistance Acinetobacter bauamnnii, this provides good early-stage study basis to research and develop novel overriding resistance Acinetobacter bauamnnii drug, brings dawn without the available predicament of medicine to solve clinically drug resistance Acinetobacter bauamnnii infection.Using extract the preventing and treating to drug resistance Acinetobacter bauamnnii of field pennycress, method is quick, cheap, and it is convenient to operate.
Description
Technical field
The present invention relates to field of biotechnology, more particularly, to Herba Patriniae extract to prepare overriding resistance Bao Man motionless
Application in bacillus drug.
Background technique
Acinetobacter bauamnnii is one of the most common type non-fermented Gram-negative bacteria in acinetobacter, belongs to opportunistic
Bacterium is classified as the superbacteria for needing override to solve by the World Health Organization.The bacterium can be faced in hospital environment with long-term surviving
The distribution of bed department is mainly most with ICU, is secondly Respiratory Medicine.Gerontal patient, Abwehrkraft des Koepers be weak and the patient of critical illness,
And using various store periods and be used for a long time broad-spectrum antibiotic therapy patient be susceptible object.Acinetobacter bauamnnii tool
There is the ability for being quickly obtained and propagating drug resistance, drug resistance Acinetobacter bauamnnii shows worldwide fashion trend, it has also become China
One of most important pathogen of nosocomial infection.It is shown according to CHINET bacterial drug resistance monitoring network data in 2018, China 35
Teaching hospital, family Acinetobacter bauamnnii, which accounts for about, is clinically separated the 14.7% of gram-negative bacteria, is only second to escherichia coli and pneumonia gram
The primary bacterium of thunder.And in terms of to clinical common antibiotics drug resistance, Acinetobacter bauamnnii is to penicillins, cephalosporins, carbon mould
Alkenes, the beta-lactam class antibiotic/compound formulation of beta lactamase restrainer, fluoroquinolones, the resistant rate of aminoglycoside
Reach 45.7-80.4%, only there is lower resistant rate to tigecycline and polymyxins.But polymyxins has biggish kidney
Toxicity and constrain its clinical application, and tigecycline is expensive, and there are some defects for its distribution and metabolism, it would be highly desirable to which development is new
Type overriding resistance Acinetobacter bauamnnii drug.
Heat-clearing and detoxifying herb has accumulated experience abundant in terms of the treatment of infectious diseases.Early in Han dynasty treatise on Febrile Diseases
Just summarize many effective prescriptions, such as Xiexin Tang, gegen qinlian decoction, baitouweng decoction.Think now with many scholars
Treatise on Febrile Diseases as classical works it is practical be exactly an infectious diseases monograph, Qing Dynasty's " pestilence opinion ", " Wen Bing Tiao Bian " etc. write
The appearance of work, so that the Couple herbs of infectious diseases have obtained further enriching, it is anti-infective for further investigation traditional Chinese medicine
Treatment provides precious resources.Domestic and foreign scholars have done a lot of work to Chinese herbal antibacterial Effect study at present, test and face
Bed research all obtains certain achievement.However, these researchs are mostly antibacterial activity in vitro research, to high toxicity, pharmacokinetics
The compound of matter difference and In vitro-in vivo correlation difference lacks effective elimination method, therefore fails to obtain reliable result of study always.
" 16 kinds of Chinese herbal granules study general drug resistance Acinetobacter bauamnnii In Vitro Bacteriostatic, 2015, Tan Junqing " research
It has been shown that, Herba Patriniae extract has In Vitro Bacteriostatic to drug resistance Acinetobacter bauamnnii in larger concentration, and Fructus Forsythiae mentions
Take the outer overriding resistance Acinetobacter bauamnnii activity of object preferably.However our studies have shown that forsythia suspense extractions in vivo almost without
Overriding resistance Acinetobacter bauamnnii activity.Therefore, have for the internal and external activity of drug resistance Acinetobacter bauamnnii very big
Difference.Field pennycress (Classification system: Thlaspi arvense Lin n.), is called Thlaspi, penny cress, is under Papaverales herba thlaspis genus
Plant, be born in patana, roadside.In addition to northwest, it is distributed all over China.It is herbaceous plant, and acrid flavour, hardship are used for
There is strong foot odour taste when Chinese medicine infusion, there is clearing heat and detoxicating, removing blood stasis and expelling pus and other effects.It there are no its internal antimicrobial agent at present
Report.
Summary of the invention
The present invention is directed to overcome in the prior art not yet discovery insufficient, research for the effective Chinese medical extract of drug-fast bacteria
It was found that a kind of new internal overriding resistance Acinetobacter bauamnnii drug, i.e. Herba Patriniae extract.
It is an object of the present invention to provide field pennycress and Herba Patriniae extract in preparing overriding resistance Acinetobacter bauamnnii drug
Using.
To achieve the goals above, the present invention is achieved by the following technical programs:
Inventor establishes drug resistance Acinetobacter bauamnnii-Caenorhabditis elegans infection model, is extracted using it to field pennycress
The activity in vivo of the overriding resistance Acinetobacter bauamnnii of object is detected, as the result is shown its can significantly improve Caenorhabditis elegans at
Motility rate illustrates that it has good biological control effect to overriding resistance Acinetobacter bauamnnii, is conducive to field pennycress and solves superbacteria
Have accumulated good theoretical basis and practical experience.
Therefore claimed field pennycress is preparing the application in overriding resistance Acinetobacter bauamnnii drug.
The present invention is also claimed Herba Patriniae extract and is preparing the application in overriding resistance Acinetobacter bauamnnii drug.
Wherein, the Acinetobacter bauamnnii is drug resistance Acinetobacter bauamnnii.
The anti-Acinetobacter bauamnnii drug is the drug of internal anti-Acinetobacter bauamnnii.
The drug resistance refers to penicillins, cephalosporins, Carbapenems, beta-lactam class antibiotic/beta-lactam
Compound formulation, fluoroquinolones and/or the aminoglycoside medicaments of enzyme inhibitor have drug resistance.
Furthermore it is preferred that the Herba Patriniae extract is 95% ethanol extract of field pennycress.
It is highly preferred that the preparation method of the Herba Patriniae extract the following steps are included:
S1. field pennycress is mixed with 95% ethyl alcohol according to mass ratio 1:5~20,80~90 DEG C of heating and refluxing extractions 1~
2h is separated by solid-liquid separation；
S2. the solid that step S1 is obtained is mixed with 95% ethyl alcohol according to mass ratio 1:5~20,80~90 DEG C are heated back
Stream extracts 1~2h, is separated by solid-liquid separation；
S3. merge the liquid that step S1 is obtained and the liquid that step S2 is obtained, removal solvent obtains drug extract.
It is highly preferred that the mass ratio of field pennycress and 95% ethyl alcohol is 1:12 in step S1.
It is highly preferred that extraction conditions are 85 DEG C of extraction 1.5h in step S1 and S2.
It is highly preferred that the mass ratio of solid and water is 1:8 in step S2.
Compared with prior art, the invention has the following beneficial effects:
The invention discloses Herba Patriniae extracts to prepare the application in overriding resistance Acinetobacter bauamnnii drug.Benefit of the invention
The nematode for having infected drug resistance Acinetobacter bauamnnii is treated with the extract of field pennycress, shows the extract of field pennycress to resistance to
Medicine Acinetobacter bauamnnii has good bactericidal effect, this is provided well to research and develop novel overriding resistance Acinetobacter bauamnnii drug
Early-stage study basis, for solve clinically drug resistance Acinetobacter bauamnnii infection bring dawn without the available predicament of medicine.It utilizes
The extract of field pennycress is prevented and treated drug resistance Acinetobacter bauamnnii, and method is quick, cheap, and it is convenient to operate.
Specific embodiment
The present invention is made below with reference to specification and specific embodiment and further being elaborated, the embodiment is only used
In explaining the present invention, it is not intended to limit the scope of the present invention.Test method as used in the following examples is such as without special theory
It is bright, it is conventional method；Used material, reagent etc., unless otherwise specified, for the reagent and material commercially obtained
Material.
The preparation of 1 Herba Patriniae extract of embodiment and its detection of bacteriostatic activity
One, experimental method
1, the preparation of Herba Patriniae extract
Three parts of field pennycress are weighed, every part of 2g is respectively placed in 3 100mL round-bottomed flasks, by the material ratio of 1:12, respectively
The different solvent 24mL of water, 50% ethyl alcohol, three kinds of 95% ethyl alcohol is added；The flask of three different extracting solutions is respectively set different
Extracting temperature is 100 DEG C, 90 DEG C, 85 DEG C, by medical filtration after heating and refluxing extraction 1.5h；Distinguish again by the material ratio of 1:8
Corresponding extracting solution is added, 100 DEG C, 90 DEG C, 85 DEG C of extraction 1.5h, filter and merge whole medical fluids, be evaporated off under reduced pressure whole respectively
Solvent obtains drug extract, is weighed and placed in 1.5mL centrifuge tube, places in -20 DEG C of refrigerators stand-by.Three kinds of Patrinia scaniosaefolias are prepared
Grass extract (water extract of field pennycress, 50% ethanol extract of field pennycress, field pennycress 95% ethanol extract).
2, drug resistance Acinetobacter bauamnnii-Caenorhabditis elegans infection model
It is using 20% brain heart infusion (BHI) fluid nutrient medium containing 10 μm of ol iron ions that synchronized nematode is raw from nematode
It rinsing on long culture medium into 15mL centrifuge tube, 800rpm revolving speed is centrifuged 1min, discards supernatant liquid, and add culture medium to 2mL or so,
Being placed in temperature is 25 DEG C, spare in the insulating box that humidity is 85%；20%BHI is poured into 3mL opacity tube, from Luria-
It is sufficiently mixed in opacity tube with sterile swab stick picking drug resistance Acinetobacter bauamnnii single bacterium colony on Bertan (LB) agar plate
It is even, bacteria concentration is adjusted to 0.5 maxwell unit (about 1 × 10 using than turbid instrument8CFU/mL 250 μ L), then with liquid-transfering gun are sucked out extremely
In new 5mL centrifuge tube, 2250 μ L of 20%BHI fluid nutrient medium is added, bacterium solution is diluted 10 times to 1 × 107CFU/mL；With
The bacterium solution that the liquid-transfering gun of 1000 μ L draws after 2mL dilution is added in nematode pipe, makes final concentration of the 5 of drug resistance Acinetobacter bauamnnii
×106CFU/mL, being put into temperature later is 25 DEG C, is cultivated in the constant temperature and humidity incubator that humidity is 85%；It is incubated for infection 6h altogether
Afterwards, it is cleaned at least 3 times with M9 fluid nutrient medium, 180 μ L of draw solution is assigned in 96 orifice plates, and 15~20, every hole is advisable.System
It is standby to obtain drug resistance Acinetobacter bauamnnii-Caenorhabditis elegans infection model.
3, Herba Patriniae extract antibacterial activity in vivo detects
The drug resistance Acinetobacter bauamnnii being prepared using previous step-Caenorhabditis elegans infection model is carried out field pennycress and mentioned
Object antibacterial activity in vivo is taken to detect.
Using the polymyxin B of 20 μ g/mL as positive controls, using 10% DMSO as negative control group, with difference
Field pennycress (water, 50% ethyl alcohol, 95% second of concentration (10000 μ g/mL, 1000 μ g/mL, 100 μ g/mL, 10 μ g/mL, 1 μ g/mL)
Alcohol) for extract as experimental group, every group sets 3 groups of parallel controls.
The Herba Patriniae extract preparation method of various concentration: weighing the extract of 10mg into 1.5mL centrifuge tube, is added
The DMSO of 100 μ L, the BHI culture medium for adding 900 μ L are sufficiently mixed dissolution extract, and 100 μ L are then successively sucked out and are added
900 μ L BHI culture mediums are serially diluted 5 times, and respectively 10000 μ g/mL, 1000 μ g/mL, 100 μ g/mL, 10 μ g/mL, 1 μ are obtained
The extracting solution of g/mL.
20 μ L Herba Patriniae extracts are separately added into corresponding aperture, make Herba Patriniae extract with 1000 μ g/mL, 100 μ g/
ML, 10 μ g/mL, 1 μ g/mL, 0.1 μ g/mL gradient final concentration extract intervened；After being incubated for 36h in 25 DEG C of insulating box,
Therapeutic effect of the Chinese medical extract to infection nematode of various concentration is judged by the survival rate of nematode.With negative control and the positive
Control is as control.
Two, experimental result is shown in Table 1.
Table 1:
The results show that Herba Patriniae extract, including water extract and alcohol extract, there is obvious overriding resistance Bao Man in vivo not
Lever bacterium effect, wherein 95% ethanol extract of field pennycress has better biological control nematode relative to water extract
Effect, the survival rate for infecting nematode can reach 10% or more.
The preparation of 1 forsythia suspense extraction of reference examples and its detection of bacteriostatic activity
One, experimental method
The preferable forsythia suspense extraction of external overriding resistance Acinetobacter bauamnnii activity being had verified that with this field is control,
The preparation of forsythia suspense extraction and its detection of bacteriostatic activity are carried out according to 1 method of embodiment.
Two, experimental result is shown in Table 2.
Table 2:
The results show that the results show that forsythia suspense extraction influences very little to the survival rate of infection nematode, without internal overriding resistance Bao
The effect of graceful acinetobacter calcoaceticus.
Claims (10)
1. field pennycress is in anti-Acinetobacter bauamnnii or prepares application in anti-Acinetobacter bauamnnii drug.
2. Herba Patriniae extract is in anti-Acinetobacter bauamnnii or prepares application in anti-Acinetobacter bauamnnii drug.
3. application according to claim 1 or claim 2, which is characterized in that the anti-Acinetobacter bauamnnii drug is internal anti-Bao Man
The drug of acinetobacter calcoaceticus.
4. application according to claim 1 or claim 2, which is characterized in that the Acinetobacter bauamnnii is drug resistance Acinetobacter bauamnnii.
5. applying according to claim 4, which is characterized in that the drug resistance refers to green to penicillins, cephalosporins, carbon
Mould alkenes, beta-lactam class antibiotic/beta lactamase restrainer compound formulation, fluoroquinolones and/or aminoglycoside medicine
Object has drug resistance.
6. applying according to claim 2, which is characterized in that the Herba Patriniae extract is that 95% ethyl alcohol of field pennycress extracts
Object.
7. applying according to claim 6, which is characterized in that the preparation method of the Herba Patriniae extract includes following step
It is rapid:
S1. field pennycress is mixed with 95% ethyl alcohol according to mass ratio 1:5~20,80~90 DEG C of 1~2h of heating and refluxing extraction, Gu
Liquid separation；
S2. the solid that step S1 is obtained is mixed with 95% ethyl alcohol according to mass ratio 1:5~20,80~90 DEG C are heated to reflux and mention
1~2h is taken, is separated by solid-liquid separation；
S3. merge the liquid that step S1 is obtained and the liquid that step S2 is obtained, removal solvent obtains drug extract.
8. applying according to claim 7, which is characterized in that in step S1, field pennycress and the mass ratio of 95% ethyl alcohol are
1:12.
9. applying according to claim 7, which is characterized in that extraction conditions are 85 DEG C of extraction 1.5h in step S1 and S2.
10. applying according to claim 7, which is characterized in that in step S2, the mass ratio of solid and water is 1:8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910493121.7A CN110302282A (en) | 2019-06-06 | 2019-06-06 | Herba Patriniae extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910493121.7A CN110302282A (en) | 2019-06-06 | 2019-06-06 | Herba Patriniae extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110302282A true CN110302282A (en) | 2019-10-08 |
Family
ID=68075210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910493121.7A Pending CN110302282A (en) | 2019-06-06 | 2019-06-06 | Herba Patriniae extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110302282A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111920875A (en) * | 2020-09-08 | 2020-11-13 | 江西中医药大学 | Patrinia extract with anti-atherosclerosis effect |
| CN113499379A (en) * | 2021-08-17 | 2021-10-15 | 贵州中医药大学 | Application of herba patriniae in preparation of methicillin-resistant staphylococcus epidermidis resistant medicine |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101829075A (en) * | 2010-04-27 | 2010-09-15 | 中国人民解放军第三军医大学第一附属医院 | Applications of kukoamine A and kukoamine B |
| CN105326872A (en) * | 2015-11-25 | 2016-02-17 | 广东药学院 | Preparation method for herba patriniae extract with therapeutical effect on ulcerative colitis |
| CN107243037A (en) * | 2017-08-12 | 2017-10-13 | 河南中医药大学 | Application of the field pennycress general flavone in treatment focal cerebral ischemia medicine is prepared |
| CN108524866A (en) * | 2018-05-08 | 2018-09-14 | 中商华夏物产（贵州）贵和堂药业有限公司 | A kind of Traditional Chinese medicine bacteriostatic gelling agent and preparation method thereof |
-
2019
- 2019-06-06 CN CN201910493121.7A patent/CN110302282A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101829075A (en) * | 2010-04-27 | 2010-09-15 | 中国人民解放军第三军医大学第一附属医院 | Applications of kukoamine A and kukoamine B |
| US20170189355A1 (en) * | 2010-04-27 | 2017-07-06 | Tianjin Chase Sun Pharmaceutical Co., Ltd. | Use of kukoamine a and kukoamine b |
| CN105326872A (en) * | 2015-11-25 | 2016-02-17 | 广东药学院 | Preparation method for herba patriniae extract with therapeutical effect on ulcerative colitis |
| CN107243037A (en) * | 2017-08-12 | 2017-10-13 | 河南中医药大学 | Application of the field pennycress general flavone in treatment focal cerebral ischemia medicine is prepared |
| CN108524866A (en) * | 2018-05-08 | 2018-09-14 | 中商华夏物产（贵州）贵和堂药业有限公司 | A kind of Traditional Chinese medicine bacteriostatic gelling agent and preparation method thereof |
Non-Patent Citations (7)
| Title |
|---|
| JIAN LI,ET AL: "In Vitro Activity of Various Antibiotics in Combination", 《MICROBIAL DRUG RESISTANCE》 * |
| 周杨杨，等: "2015版中国药典清热、解毒类中药材的抗菌作用", 《中国抗生素杂志》 * |
| 杨相海，等: "鲍曼不动杆菌细胞膜屏障组成成分", 《山东医药》 * |
| 段欣冉，等: "中药抑制鲍曼不动杆菌的研究进展", 《中国感染控制杂志》 * |
| 段欣冉: "高通量筛选平台用于清热解毒中药的体内抗菌活性研究", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》 * |
| 谭俊青，等: "16种中药颗粒剂对泛耐药鲍曼不动杆菌体外抑菌活性研究", 《按摩与康复医学》 * |
| 赵娜，等: "10 味中药对耐药性鲍曼不动杆菌抑菌效果的实验研究", 《湖南中医杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111920875A (en) * | 2020-09-08 | 2020-11-13 | 江西中医药大学 | Patrinia extract with anti-atherosclerosis effect |
| CN113499379A (en) * | 2021-08-17 | 2021-10-15 | 贵州中医药大学 | Application of herba patriniae in preparation of methicillin-resistant staphylococcus epidermidis resistant medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178862B (en) | Preparation and quality detection methods of Xianglian disinfectant | |
| CN110302282A (en) | Herba Patriniae extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN111529623B (en) | Yin-nourishing and sore-throat-relieving pharmaceutical composition | |
| CN107870216A (en) | The spectrum effect of polygonum capitatum opposed polarity position bacteriostasis learns analysis method | |
| CN108719204A (en) | A kind of drug resistance Acinetobacter bauamnnii infects method for building up and its application of Caenorhabditis elegans medicaments sifting model | |
| CN105963339A (en) | Application of folium archidendri clypeariae extract in preparation of multidrug-resistant pseudomonas aeruginosa drug | |
| CN103585209B (en) | Dorema ammoniacum resin extract is preparing the application in medicines resistant to liver cancer | |
| CN105770008A (en) | New application of folium syringae extract in preparing drugs for resisting drug-resistant bacterium infection diseases | |
| CN108853358B (en) | Antibacterial traditional Chinese medicine composition and preparation method and application thereof | |
| CN104651473B (en) | The method for determining the sub-lethal dose staphylococcus aureus resistance to the action of a drug and drug resistance simultaneously | |
| CN110302308A (en) | Pseudobulbus Cremastrae seu Pleiones extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN110269885A (en) | Radix Tinosporae extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN105456306B (en) | Rattan lycopod extract is preparing the application in antibacterial anti-inflammatory natural drug | |
| CN110269923A (en) | Turmeric P.E is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN110302219A (en) | Cortex Pseudolaricis extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN101612204B (en) | Medicament-resistant inhibitor for porcine streptococcus | |
| CN102397333A (en) | Preparation and quality detection methods of honeysuckle flower-baikal skullcap root injection | |
| CN103432214B (en) | Preparation method and application of effective components of polygonum capitatum | |
| CN108686055A (en) | Application of the Lemna paucicostata in anti-Staphylococcus aureus drug | |
| CN110464802A (en) | Compound dendrobium officinale mouth sprays and preparation method thereof | |
| CN105079289B (en) | Fermented Chinese gall herb and tea leaves are preparing the application in Anti-helicobacter pylori drugs | |
| Abdullahi et al. | Antibacterial Activity of the Leaf Extract of Alchornea Cordifolia (Christman Bush) Against Selected Bacteria Isolates | |
| CN105646194B (en) | The preparation and application of artemisia anomalas extract 3,4- dihydroxycinnamic acids | |
| CN108210531A (en) | Purposes of the Essential Oil of Radix Angelicae Dahuricae in antibacterials are prepared | |
| CN105395538B (en) | A kind of pharmaceutical composition treating acute upper respiratory tract infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191008 |